Please Scroll Down to See Forums Below
napsgear
genezapharmateuticals
domestic-supply
puritysourcelabs
UGL OZ
UGFREAK
napsgeargenezapharmateuticals domestic-supplypuritysourcelabsUGL OZUGFREAK

Stacking Superdrol with Injectables???

harleystephens

New member
My brother has gotten me interested in trying a cycle of Fina. I just finished a mild cycle of Superdrol and am wondering if any of you have input on taking OTC Superdrol (Testosterone) in combination with an Injectable Steroid such as Fina...

Thnx,
Harley
 
Thanks... Maybe you can answer this Question for me then abour Superdrol... What is it Exactly?? Is it a form of Testosterone, a precurser, HGH, etc...??
 
superdrols chemical structure is 2,17 di-methyl dihydrotestosterone. The propionate(on carbon 17) ester version of this compound was once used to treat a certain type of breast cancer, I believe it was a form that is highly estrogen sensitive, with modern science and drug development they now use drugs with a safer profile on women ,the methyl group on carbon 2 is thought to act in two different ways. 1 provided some sort of interaction decreasing aromatase activity, 2- provides steric hindrance to the 3 keto group, which in return will increase half life(by possibly decreasing transformation into a 3 OH). Half life of 2 methyl DHT is aprox 5.3 hours . superdrol has a 17 alpha methyl added, so i suspect the half life to be increased, to what degree i cant say without the data,( in some sense i wonder about cumulative toxicity on a 3 a day dose,maybe 10-15mg twice a day would be better), if available from AX, and they are willing.

here is the gc and mass spec of 2alpha methyl DHT.

The metabolism of dromostanolone (2á-methyl-5á - androstan-17â-ol-3-one) was studied in three adult volunteers after oral dose of 20 mg. Solvent extracts of urine obtained after enzyme hydrolysis were derivatized with MSTFA/TMCS and MSTFA/TMIS. The structures of intact drug and its metabolites were determined by gas chromatography/mass spectrometry (GC/MS) in electron impact (EI) mode. The major metabolite (2á-methyl-5á- androstan-3á-ol-17-one), its 3â -epimer, parent compound, and several hydroxylated metabolites including intact drug were detected by comparing total ion chromatograms of control urine with that of the administered sample. Two epimers of 2á -methyl-5á- androstan-3,17â-diol were detected using selected ion monitoring. The maximum excretion of dromostanolone and 2á-methyl-5á- androstan-3á-ol-17-one was reached in 6.2-15 hr. The half-life of intact dromostanolone was 5.3 hr. About 3.0% of the administered amount was found to be excreted within 95 hr as unchanged form
 
Top Bottom